On March 19, 2026, the FDA announced it would not pursue more stringent regulations for indoor tanning beds, despite warnings from medical organizations regarding the associated risks of skin cancer.
This decision reflects a broader trend in regulatory approaches under the current administration, which may prioritize industry interests over public health recommendations.
The implications of this regulatory stance could affect the capacity and safety of indoor tanning facilities, potentially leading to increased health risks for users.